Mercury Biopharmaceutical Corporation (TPEX:6932)
Taiwan
· Delayed Price · Currency is TWD 8.80
-0.11 (-1.23%)
Aug 15, 2025, 1:46 PM CST
Mercury Biopharmaceutical Market Cap
Mercury Biopharmaceutical has a market cap or net worth of 3.72 billion as of August 15, 2025. Its market cap has decreased by -42.60% in one year.
Market Cap
3.72B
Enterprise Value
3.54B
Revenue
4.96M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.80
Market Cap Chart
Since December 23, 2022, Mercury Biopharmaceutical's market cap has decreased from 5.10B to 3.72B, a decrease of -27.02%. That is a compound annual growth rate of -11.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 3.72B | -32.25% |
| Dec 31, 2024 | 5.50B | -29.32% |
| Dec 29, 2023 | 7.78B | 94.15% |
| Dec 30, 2022 | 4.01B | -21.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 208.61B |
| PharmaEssentia | 169.30B |
| Bora Pharmaceuticals Co., LTD. | 94.94B |
| Lotus Pharmaceutical | 53.91B |
| Oneness Biotech | 32.23B |
| Lumosa Therapeutics | 27.69B |
| Polaris Group | 27.62B |
| Center Laboratories | 26.85B |